Clinical Trial Finds Administering Potassium at 3.6 mEq/L as Effective as Standard 4.5 mEq/L Threshold Post Cardiac Surgery
Advertisement
A new study has shown that a lower threshold for potassium supplementation after cardiac surgery saves patient costs and does not create any further risks of atrial fibrillation or other dysrhythmias.
It’s common practice for patients to receive intravenous potassium supplementation after any form of heart surgery if their potassium levels drop below 4.5 mEq/L (Milliequivalents per litre). However, a new clinical trial whose results are published in JAMA, suggests that potassium supplementation only at levels below 3.6 mEq/L is non-inferior to standard practice as a way to lower the risk of atrial fibrillation (AFib) after surgery.
The risk of AFib increases with age, but it can sometimes occur among young people. People with AFib may have a much faster heart rate than usual, and the heart does not pump blood around the body efficiently. Blood may collect or pool in the heart, increasing the likelihood of clots.
it is the most frequent postoperative adverse event, and according to the authors of the new study, it can lead to expensive hospital bills, longer hospital stays, and a higher risk of death.
Researchers conducted a randomized clinical trial at 23 cardiac surgical centers utilizing 1,690 patients with no history of atrial dysrhythmias who were scheduled for isolated coronary artery bypass grafting surgery.
Of those, 843 were in the group with the “relaxed” standard for supplementation. The lowered threshold for potassium supplementation did not result in any further adverse developments or increased heart dysrhythmias, and the cost savings per patient in the “relaxed” group had a mean difference of $111.89.
Reference: O’Brien B, Campbell NG, Allen E, et al. Potassium Supplementation and Prevention of Atrial Fibrillation After Cardiac Surgery: The TIGHT K Randomized Clinical Trial. JAMA. Published online August 31, 2024. doi:10.1001/jama.2024.17888
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.